Interestingly, in patients with DN, the levels of serum TNF-α and its receptor are elevated and are indicative of both renal functional decline and progression to end-stage renal disease [59,60], and inhibiting TNF-α notably alleviated glomerular lesions in murine models of DN [61]. This evidence concerns the gene TNF and liver dysplastic nodule.